TY - JOUR T1 - Reproducibility and transparency characteristics of oncology research evidence JF - medRxiv DO - 10.1101/19001917 SP - 19001917 AU - Corbin G Walters AU - Zachery J Harter AU - Cole Wayant AU - Nam Vo AU - Michael Warren AU - Justin Chronister AU - Daniel Tritz AU - Matt Vassar Y1 - 2019/01/01 UR - http://medrxiv.org/content/early/2019/07/14/19001917.abstract N2 - Introduction As much as 50%-90% of research is estimated to be irreproducible, costing upwards of $28 billion in the United States alone. Reproducible research practices are essential to improving the reproducibility and transparency of biomedical research, such as including pre-registering studies, publishing a protocol, making research data and metadata publicly available, and publishing in open access journals. Here we report an investigation of key reproducible or transparent research practices in the published oncology literature.Methods We performed a cross-sectional analysis of a random sample of 300 oncology studies published from 2014-2018. We extracted key reproducibility and transparency characteristics in a duplicative fashion by blinded investigators using a pilot tested Google Form.Results Of the 300 studies randomly sampled, 296 studies were analyzed for study reproducibility characteristics. Of these 296 studies, 194 were contained empirical data that could be analyzed for reproducible and transparent research practices. Raw data was available for 9 studies (4.6%). Approximately 5 studies (2.6%) provided a protocol. Despite our sample including 15 clinical trials and 7 systematic reviews/meta-analyses, only 7 included a pre-registration statement. Less than 25% (65/194) of studies provided an author conflict of interest statement.Discussion We found that key reproducibility and transparency characteristics were absent from a random sample of published oncology studies. We recommend required pre-registration for all eligible trials and systematic reviews, published protocols for all manuscripts, and deposition of raw data and metadata in public repositories.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded through the 2019 Presidential Research Fellowship Mentor ? Mentee Program at Oklahoma State University Center for Health Sciences Author DeclarationsAll relevant ethical guidelines have been followed and any necessary IRB and/or ethics committee approvals have been obtained.Not ApplicableAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.Not ApplicableAny clinical trials involved have been registered with an ICMJE-approved registry such as ClinicalTrials.gov and the trial ID is included in the manuscript.Not ApplicableI have followed all appropriate research reporting guidelines and uploaded the relevant Equator, ICMJE or other checklist(s) as supplementary files, if applicable.Not ApplicableStudy protocol, raw data, and other pertinent materials are available on the Open Science Framework (https://osf.io/x24n3/). https://osf.io/x24n3/ ER -